Maximilian Niyazi

LMU Klinikum, Ludwig-Maximilians-Universität München

Papers

2

Total Citations

112

H-Index

2

About

Maximilian Niyazi is a leading figure in radiation oncology, whose work has fundamentally shaped the precision and efficacy of stereotactic radiosurgery (SRS) for intracranial tumors. His research centers on advanced treatment planning, target delineation, and the integration of novel imaging technologies to improve patient outcomes. Niyazi’s most influential contribution is his seminal work on optimal radiosurgical dosing for pituitary tumors, a study cited over 96 times that established critical guidelines for single-fraction and multi-fraction SRS delivery using systems like Gamma Knife and CyberKnife. This research directly informs clinical protocols for managing residual or recurrent pituitary adenomas. Further demonstrating his impact on treatment precision, Niyazi pioneered the integration of stereoscopic X-ray imaging with cone-beam CT for automatic couch positioning in stereotactic radiotherapy. His preliminary results from this cross-modality installation, though less cited, laid essential groundwork for reducing positioning errors and enhancing the accuracy of intracranial tumor treatments. Through these contributions, Niyazi has advanced the field by marrying rigorous dosimetric analysis with cutting-edge imaging, setting new standards for safe and effective radiosurgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
112
Total Citations
56
Avg Citations/Paper
🏆 Most Cited Paper
Target delineation and optimal radiosurgical dose for pituitary tumors
96 citations · 2016
📈 Most Prolific Year: 2016 (2 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: LMU Klinikum, Ludwig-Maximilians-Universität München

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago